Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy
High prevalence of placental-derived complications, such as preeclampsia and intrauterine growth restriction, has been reported in women with breast cancer (BC) treated with chemotherapy during pregnancy (PBC-CHT). Aim: To ascertain whether PBC-CHT is associated with an imbalance of angiogenic facto...
Main Authors: | Cristina Saura, Olga Sánchez, Sandra Martínez, Carmen Domínguez, Rodrigo Dienstmann, Fiorella Ruíz-Pace, Maria Concepció Céspedes, Ángeles Peñuelas, Javier Cortés, Elisa Llurba, Octavi Córdoba |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/4/923 |
Similar Items
-
Delineating Pro-Angiogenic Myeloid Cells in Cancer Therapy
by: Benjamin W. Johnson, et al.
Published: (2018-08-01) -
Adaptive hypofractionated radiotherapy combined with chemotherapy and anti-angiogenic therapy for residual and recurrent glioblastoma after surgery: A case report
by: Yuchao Ma, et al.
Published: (2020-01-01) -
Osteonecrosis of the Jaws in Patients Receiving Anti-Angiogenic Drugs and Chemotherapeutics: Literature Review and Case Reports
by: Mihaylova Z., et al.
Published: (2019-05-01) -
The Role of Anti-Angiogenics in Pre-Treated Metastatic <i>BRAF</i>-Mutant Colorectal Cancer: A Pooled Analysis
by: Fabio Gelsomino, et al.
Published: (2020-04-01) -
Prognostic Value of Angiogenic Markers in Pregnant Women With Chronic Hypertension
by: Julia Binder, et al.
Published: (2021-09-01)